The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A molecular diagnostic panel for thyroid cancer disease management.
Shih-Min Cheng
Employment or Leadership Position - Quest Diagnostics
Stock Ownership - Quest Diagnostics
Kevin Qu
Employment or Leadership Position - Quest Diagnostics
Stock Ownership - Quest Diagnostics
Adam Abdool
Employment or Leadership Position - Quest Diagnostics
Stock Ownership - Quest Diagnostics
Anthony Sferruzza
Employment or Leadership Position - Quest Diagnostics
Stock Ownership - Quest Diagnostics
Frederic Waldman
Employment or Leadership Position - Quest Diagnostics
Stock Ownership - Quest Diagnostics
Richard E Reitz
Employment or Leadership Position - Quest Diagnostics
Stock Ownership - Quest Diagnostics